Edgestream Partners L.P. Makes New $634,000 Investment in InMode Ltd. (NASDAQ:INMD)

Edgestream Partners L.P. acquired a new stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 37,399 shares of the healthcare company's stock, valued at approximately $634,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Verition Fund Management LLC raised its position in shares of InMode by 18.2% during the 3rd quarter. Verition Fund Management LLC now owns 37,196 shares of the healthcare company's stock valued at $630,000 after buying an additional 5,739 shares in the last quarter. Martingale Asset Management L P increased its stake in shares of InMode by 147.2% during the third quarter. Martingale Asset Management L P now owns 62,360 shares of the healthcare company's stock valued at $1,057,000 after buying an additional 37,135 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of InMode by 54.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 125,480 shares of the healthcare company's stock valued at $2,127,000 after purchasing an additional 44,058 shares in the last quarter. Townsquare Capital LLC purchased a new stake in InMode during the third quarter worth $202,000. Finally, Quantbot Technologies LP purchased a new position in shares of InMode in the 3rd quarter worth approximately $1,104,000. 68.04% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. BTIG Research started coverage on shares of InMode in a research note on Thursday, October 17th. They issued a "buy" rating and a $25.00 target price for the company. Barclays lowered their price target on shares of InMode from $29.00 to $27.00 and set an "overweight" rating on the stock in a report on Monday, October 14th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of InMode in a research note on Thursday, October 31st. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, InMode has an average rating of "Hold" and a consensus target price of $22.60.

InMode Stock Down 0.3 %

INMD stock traded down $0.05 during mid-day trading on Friday, hitting $18.06. 297,034 shares of the company were exchanged, compared to its average volume of 1,318,407. InMode Ltd. has a 12-month low of $14.87 and a 12-month high of $26.80. The firm has a market capitalization of $1.52 billion, a P/E ratio of 9.79 and a beta of 2.07. The business has a fifty day simple moving average of $17.79 and a 200-day simple moving average of $17.52.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.